☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Soligenix
Soligenix Entered into an Exclusive Option Agreement with Silk Road Therapeutics to Acquire Pentoxifylline for Behçet's Disease
May 2, 2023
PharmaShots Weekly Snapshot (February 10-14, 2020)
February 17, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
